NO302216B1 - Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen - Google Patents

Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen

Info

Publication number
NO302216B1
NO302216B1 NO930543A NO930543A NO302216B1 NO 302216 B1 NO302216 B1 NO 302216B1 NO 930543 A NO930543 A NO 930543A NO 930543 A NO930543 A NO 930543A NO 302216 B1 NO302216 B1 NO 302216B1
Authority
NO
Norway
Prior art keywords
dihydropyridine
zero
dosage form
pharmaceutical dosage
type calcium
Prior art date
Application number
NO930543A
Other languages
English (en)
Norwegian (no)
Other versions
NO930543D0 (no
NO930543L (no
Inventor
Sabine Compassi
Original Assignee
Siegfried Ag Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag Pharma filed Critical Siegfried Ag Pharma
Publication of NO930543D0 publication Critical patent/NO930543D0/no
Publication of NO930543L publication Critical patent/NO930543L/no
Publication of NO302216B1 publication Critical patent/NO302216B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO930543A 1992-02-17 1993-02-16 Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen NO302216B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46492 1992-02-17

Publications (3)

Publication Number Publication Date
NO930543D0 NO930543D0 (no) 1993-02-16
NO930543L NO930543L (no) 1993-08-18
NO302216B1 true NO302216B1 (no) 1998-02-09

Family

ID=4187618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930543A NO302216B1 (no) 1992-02-17 1993-02-16 Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen

Country Status (12)

Country Link
US (1) US5439687A (cs)
JP (1) JPH061716A (cs)
CA (1) CA2086989A1 (cs)
CZ (1) CZ285177B6 (cs)
FI (1) FI930657L (cs)
HU (1) HU222252B1 (cs)
IL (1) IL104192A (cs)
MX (1) MX9300664A (cs)
NO (1) NO302216B1 (cs)
PL (1) PL172361B1 (cs)
RU (1) RU2122413C1 (cs)
SK (1) SK9793A3 (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
JP2676319B2 (ja) * 1994-02-09 1997-11-12 大洋薬品工業株式会社 塩酸ニカルジピンの徐放剤用製剤およびこれを利用した徐放化製剤
JP3148256B2 (ja) 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
MXPA01005370A (es) * 1999-09-30 2004-05-14 Penwest Pharmaceuticals Co Sistema de matriz de liberacion sostenida para farmacos altamente solubles.
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
KR100379299B1 (ko) * 2000-01-15 2003-04-10 주식회사 중외제약 펠로디핀의 가용화 방법 및 방출제어형 제제
US20030180354A1 (en) * 2001-10-17 2003-09-25 Dr. Reddy's Laboratories Limited Amlodipine maleate formulations
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
BE1014922A3 (nl) * 2002-03-01 2004-06-01 Pfizer Ltd Amlodipine als vrije base.
MXPA04009701A (es) * 2002-04-05 2005-05-27 Penwest Pharmaceuticals Co Formulaciones de metoprolol de liberacion sostenida.
ES2312525T3 (es) * 2002-05-21 2009-03-01 Watson Laboratories, Inc. Formulacion farmaceutica con liberacion prolongada.
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
WO2004014448A1 (en) * 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
BRPI0506851A (pt) * 2004-01-14 2007-06-12 Lavipharm Lab Inc dispositivo de distribuição transdérmica para distribuir antagonistas de cálcio do tipo diidropiridina contendo pelo menos um ácido graxo
PL1748762T3 (pl) * 2004-05-28 2014-05-30 Abbvie Deutschland Postać dawkowania, dająca się otrzymać ze sproszkowanej mieszaniny zawierającej nieorganiczny pigment
US20060210623A1 (en) * 2005-03-17 2006-09-21 Stach Paul E Sustained release delivery of isradipine
US20070128280A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128282A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
ES2547226T5 (es) * 2006-08-30 2020-06-12 Jagotec Ag Formulaciones de dosificación oral de liberación controlada que comprenden un núcleo y una o más capas de barrera
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
EP2124552A4 (en) * 2007-01-31 2013-01-09 Methylation Sciences Internat Srl PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF S-ADENOSYLMETHIONINE
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
KR20100069170A (ko) * 2008-12-16 2010-06-24 삼일제약주식회사 라시디핀 함유 과립 및 이를 포함하는 약학 조성물
KR101136075B1 (ko) * 2009-06-30 2012-04-17 케이엘피앤지씨앤팜 주식회사 고혈압 치료제 조성물
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
PL389530A1 (pl) 2009-11-10 2011-05-23 Fabryka Maszyn FAMUR Spółka Akcyjna Sposób przeniesienia napędu w kombajnie górniczym ścianowym
US9801896B2 (en) 2012-10-17 2017-10-31 Methylation Sciences International Srl Compositions comprising S-adenosylmethionine and a gallic acid ester
US20200121648A1 (en) * 2017-06-30 2020-04-23 Kowa Company, Ltd. Pharmaceutical composition
CN112592311B (zh) * 2021-01-03 2023-01-31 迪沙药业集团有限公司 一种硝苯地平a晶块状晶习及其控释片组合物
WO2024238657A2 (en) 2023-05-15 2024-11-21 Bonafide Health, Llc Sleep-improving compositions and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
US4893393A (en) * 1988-10-25 1990-01-16 Marshall Ben C Pipe fitting assembly tool
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
NO930543D0 (no) 1993-02-16
NO930543L (no) 1993-08-18
CA2086989A1 (en) 1993-08-18
IL104192A (en) 1998-01-04
JPH061716A (ja) 1994-01-11
CZ8193A3 (en) 1994-01-19
MX9300664A (es) 1994-07-29
PL172361B1 (pl) 1997-09-30
FI930657A7 (fi) 1993-08-18
RU2122413C1 (ru) 1998-11-27
CZ285177B6 (cs) 1999-06-16
IL104192A0 (en) 1993-05-13
US5439687A (en) 1995-08-08
HU9300424D0 (en) 1993-05-28
SK9793A3 (en) 1993-09-09
FI930657L (fi) 1993-08-18
FI930657A0 (fi) 1993-02-15
HUT64694A (en) 1994-02-28
PL297747A1 (en) 1993-11-02
HU222252B1 (hu) 2003-05-28

Similar Documents

Publication Publication Date Title
NO302216B1 (no) Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen
FI940787A7 (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
FI963984L (fi) Uusi oraalinen farmaseuttinen annostelumuoto
FI914765A7 (fi) Hidastetusti vapauttava oraalinen lääkeannosmuoto
IT8867302A0 (it) Forma di dosaggio per rilascio continuato di sostanze farmaceutiche esimili
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
FI946043L (fi) Sokeripäällysteinen farmaseuttinen annosyksikkö
FI905684A7 (fi) Farmaseuttinen annosmuoto kalojen lääkintään
FI913608A7 (fi) Annosmuoto kalsiumantagonistin annostelemiseksi
EE03378B1 (et) Omeprasooli magneesiumisoola sisaldav peroraalne ravimvorm
NO934145L (no) Farmasöytiske forbindelser
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
FI931251A7 (fi) Farmaseuttisia yhdisteitä
IL102003A0 (en) Pharmaceutical formulation of a benzodiazepine
ITMI922885A0 (it) Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
EE9600050A (et) Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks
FI903885A7 (fi) Biosaatavuutta parantava uusi suun kautta otettava farmaseuttinen annosmuoto
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
UA1257S (uk) Розподілювач фармацевтичних таблеток
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
NO912497D0 (no) Doseringsform for administrering av kalsiumantagonist.
DK117291D0 (da) Doseringsform til oral indgift af laegemiddelstoffer
ATA286987A (de) Pharmazeutisches kombinationspräparat mit einem calcium-antagonisten und einem ace-hemmer
IL105714A0 (en) Oral dosage forms of risedronate
AUPM590295A0 (en) Manufacture of pharmaceutical dosage forms

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees